Reports and Findings
Research
END RHDGlenn Jonathan Katharine Rosemary Pearson Carapetis AM Noonan Wyber BA (Education) PhD Candidate AM MBBS FRACP FAFPHM PhD FAHMS MBBS (Hons) MSc MBChB MPH FRACGP PhD Director of First Nations Strategy and Leadership; Co-Head, Strep A Translation
Research
Development of methods to rapidly track pathogen and antibiotic resistance profiles from skin sores in Northern Australia (Hot North)Asha Jonathan Marianne Tim Bowen Carapetis AM Mullane Barnett BA MBBS DCH FRACP PhD GAICD FAHMS OAM AM MBBS FRACP FAFPHM PhD FAHMS BSc (OT) PhD Head, Healthy Skin and ARF Prevention Executive Director; Co-Head, Strep A Translation; Co-Founder of
Research
Development of a longer acting formulation of Penicillin G for the treatment and prevention of acute rheumatic fever and rheumatic heart diseaseJonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep A Translation; Co-Founder of REACH Professor Carapetis is
Research
Developing a human challenge model of GAS infectionJonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep A Translation; Co-Founder of REACH Professor Carapetis is
Research
Defining target penicillin concentrations for subsequent studies of a reformulated long-acting benzathine penicillin prototypeJonathan Tim Carapetis AM Barnett AM MBBS FRACP FAFPHM PhD FAHMS PhD Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Head, Strep A Pathogenesis and Diagnostics 08 6319 1000 contact@thekids.org.au timothy.barnett@thekids.org.au
Research
Defining Group A Streptococcus interaction with the tonsil epithelium to inform vaccine developmentAnthony Jonathan Tim Kicic Carapetis AM Barnett BSc (Hons) PhD AM MBBS FRACP FAFPHM PhD FAHMS PhD Rothwell Family Fellow; Head, Airway Epithelial Research Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Head, Strep A
Research
Controlled Human Infection for Penicillin Against Streptococcus pyogenes – a double blinded randomised trail (The CHIPS trial)Jonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep A Translation; Co-Founder of REACH Professor Carapetis is
Research
Coalition to Advance Vaccines Against Group A Streptococcus (CANVAS): A Trans-Tasman Initiative Against Rheumatic FeverInvestigators: Amy Baker, Jeffrey Cannon, Jonathan Carapetis, Katherine Gray, Yue Wu External collaborators: University of Auckland: Nikki Moreland, John Fraser, Diana Lennon Otago University: Michael Baker Griffith University: Michael Good, Michael
Research
Burden of rheumatic heart disease (RHD) and impact of prevention strategies: comprehensive evidence to drive the RHD EndgameJonathan Judy Rosemary Carapetis AM Katzenellenbogen Wyber AM MBBS FRACP FAFPHM PhD FAHMS BSc (Occ Ther) BSc Hons (Epidemiol) MSc PhD MBChB MPH FRACGP PhD Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Honorary Research
Research
BPG Formulation Preferences Study: Exploring patient, family and clinician reformulations preferences for BPGJonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep A Translation; Co-Founder of REACH Professor Carapetis is